Roivant Sciences Ratios (2020-2025) | ROIV

Ratios Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 88.58%45.96%88.10%90.41%54.38%94.31%60.04%70.95%78.97%80.51%93.89%98.73%97.33%94.77%97.13%92.90%92.93%
EBT Margin -428.68%-3,989.95%-4,796.89%-1,305.56%-1,610.35%-1,257.33%-8,098.75%-2,503.44%-2,240.66%-1,508.01%-6,617.49%33,116.21%-245.81%-5,014.15%-2,600.50%-12,408.39%-10,123.74%
EBIT Margin -7,262.25%-11,832.28%-4,505.57%-1,995.95%-4,893.32%-1,010.73%-6,536.44%-2,240.21%-2,217.20%-1,278.27%-5,863.24%32,948.56%-1,279.54%-7,636.04%-3,042.59%-13,130.05%-19,492.87%
EBITDA Margin -7,262.25%-11,832.28%-4,505.57%-1,995.95%-4,893.32%-1,010.73%-6,536.44%-2,240.21%-2,217.20%-1,278.27%-5,863.24%32,948.56%-1,279.54%-7,636.04%-3,042.59%-13,130.05%-19,492.87%
Operating Margin -7,262.25%-11,832.28%-4,505.57%-1,995.95%-4,893.32%-1,010.73%-6,536.44%-2,240.21%-2,217.20%-1,278.27%-5,863.24%32,948.56%-1,279.54%-7,636.04%-3,042.59%-13,130.05%-19,492.87%
Net Margin -506.15%-4,043.69%-4,792.99%-1,306.76%-1,613.21%-1,257.49%-8,191.34%-2,520.71%-2,257.19%-1,516.12%-2,264.75%-376.01%1,115.06%-962.75%3,626.30%-12,622.63%-10,569.00%
FCF Margin -7,073.16%-3,146.45%-1,855.32%-881.94%-2,224.37%-6,009.28%-1,537.79%-3,960.67%-1,157.67%-5,392.05%-4,227.25%-2,425.46%-5,984.40%-7,437.06%-9,604.52%-12,317.76%
Efficiency
Inventory Average 0.00B0.00B0.01B0.02B0.03B
Assets Average 2.52B2.78B2.95B2.69B2.59B2.41B2.21B2.30B2.26B2.10B4.69B7.27B6.86B6.35B6.00B5.61B5.23B5.05B
Equity Average 2.00B2.19B2.34B2.14B1.90B1.63B1.47B1.52B1.47B1.33B3.96B6.52B6.17B5.74B5.56B5.36B5.00B4.81B
Invested Capital 2.21B2.14B2.63B2.45B2.25B2.14B1.89B1.80B1.98B1.72B1.72B6.99B6.88B6.21B5.58B5.54B5.19B4.82B4.81B
Asset Utilization Ratio 0.010.010.020.020.020.030.020.030.010.010.000.010.000.00
Leverage & Solvency
Interest Coverage Ratio -108.08-33.69-44.76-31.02-23.13542.93-7.63
Debt to Equity 0.080.100.080.090.020.020.130.140.120.160.160.030.030.03
Debt Ratio 0.070.080.060.070.010.010.090.090.080.100.100.030.030.03
Equity Ratio 0.790.800.780.800.790.680.680.650.670.620.640.900.890.910.900.960.950.960.95
Times Interest Earned -108.08-33.69-44.76-31.02-23.13542.93-7.63
Valuation
Enterprise Value 0.50B-1.39B5.07B4.29B5.07B1.74B1.28B1.02B4.74B4.37B6.72B7.98B2.82B2.48B2.57B3.57B3.81B2.81B3.63B6.39B
Market Capitalization 0.50B0.50B6.84B6.40B6.90B3.42B2.85B2.27B5.80B5.60B7.73B9.01B9.03B8.49B7.81B8.53B8.61B7.20B7.66B10.33B
Return Ratios
Return on Sales -26.74%-22.78%-17.53%-19.58%-21.77%-23.36%-24.90%-20.26%-14.75%-7.78%-3.00%8.49%4.19%-9.05%
Return on Capital Employed -0.30%-0.51%-0.48%-0.60%-0.69%-0.60%-0.60%-0.63%0.96%0.68%0.77%0.75%-0.20%-0.25%
Return on Invested Capital 0.97%0.69%0.75%0.79%-0.25%
Return on Assets -0.17%-0.24%-0.31%-0.38%-0.50%-0.62%-0.61%-0.53%-0.18%-0.06%-0.01%0.05%0.02%-0.03%
Return on Equity -0.22%-0.30%-0.39%-0.52%-0.73%-0.93%-0.94%-0.84%-0.22%-0.06%-0.02%0.06%0.02%-0.03%